Use the keywords feature with a free QxMD account.
Use Read by QxMD to access full text via your institution or open access sources.
Read also provides personalized recommendations to keep you up to date in your field.
Existing User
Sign InNew to Read
Sign Up#1
RANDOMIZED CONTROLLED TRIAL
Joan Maurel, Antonio López-Pousa, Ramón de Las Peñas, Joaquín Fra, Javier Martín, Josefina Cruz, Antonio Casado, Andrés Poveda, Javier Martínez-Trufero, Carmen Balañá, María Auxiliadora Gómez, Ricardo Cubedo, Oscar Gallego, Belen Rubio-Viqueira, Jordi Rubió, Raquel Andrés, Isabel Sevilla, Juan Jose de la Cruz, Xavier García Del Muro, Jose María Buesa
PURPOSE: To assess the progression-free survival (PFS) and antitumor response to standard-dose doxorubicin compared with sequential dose-dense doxorubicin and ifosfamide in first-line treatment of advanced soft tissue sarcoma. PATIENTS AND METHODS: Patients with measurable advanced soft tissue sarcoma, Eastern Cooperative Oncology Group (ECOG) performance status (PS) < 2, between the ages 18 and 65 years, and with adequate bone marrow, liver, and renal function were entered in the study...
April 10, 2009: Journal of Clinical Oncology
1
Make the most of Read.
Download the mobile app.
Download the mobile app.
Fetching more papers... 
